Rhythm Pharmaceuticals, Inc. (RYTM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.96B |
| Enterprise Value | 6.91B |
| P/E Ratio | -39.29 |
| PEG Ratio | -6.14 |
| Price/Sales Ratio | 28.14 |
| Price/Book Ratio | 39.04 |
| Enterprise/Revenue | 28.01 |
| Enterprise/EBITDA | -45.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.69 |
| Operating Margin | -0.67 |
| Return On Assets | -0.44 |
| Return On Equity | -0.84 |
| Revenue | 189.76M |
| Revenue/Share | 4.07 |
| Gross Profit | 170.27M |
| EBITDA | -174.12M |
| Net Income | -196.54M |
| Diluted EPS | -3.11 |
| Total Cash | 320.94M |
| Total Cash/Share | 4.65 |
| Total Debt | 3.52M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 2.78 |
| Book Value Per Share | 2.92 |
| 52-Week Change | 14.11 |
| 52-Week High | 122.2 |
| 52-Week Low | 74.5 |
| Moving Average 50 Days | 96.29 |
| Moving Average 200 Days | 97.06 |
| Average Volume | 989,698 |
| Shares Outstanding | 69.33M |
| % Held by Institutions | 113.4 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | N/A |
| Last Split Date | N/A |